Russia Immunotherapy Drugs market was valued at US$ 1.56 billion in 2024 and is projected to reach US$ 2.87 billion by 2030, at a CAGR of 10.7% during the forecast period 2024-2030. Medications that stimulate or suppress the immune system to help the body fight various diseases, including cancer. Rapid growth driven by increasing prevalence of cancer and autoimmune diseases. Rising adoption of c..